Hrt Financial LP Morphic Holding, Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$19.95 - $31.0 $260,626 - $404,984
13,064 New
13,064 $377,000
Q3 2022

Nov 14, 2022
BUY
$22.23 - $33.37 $970,806 - $1.46 Million
43,671 New
43,671 $1.24 Million
Q2 2021

Aug 16, 2021
SELL
$45.13 - $64.99 $343,258 - $494,313
-7,606 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$29.77 - $84.85 $226,430 - $645,369
7,606 New
7,606 $481,000

Others Institutions Holding MORF

# of Institutions
9
Shares Held
4.71M
Call Options Held
0
Put Options Held
0
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email